The international guidelines for diagnosing multiple sclerosis (MS), called the McDonald criteria, underwent their most ...

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...

The MarketWatch News Department was not involved in the creation of this content. Collaboration enables patients to access the Octave MSDA test at Quest's approximately 7,000 patient access sites ...

A simple blood test into multiple sclerosis (MS) pathology could speed MS diagnostics and ultimately improve patient care, according to Xiaoli Yu, Ph.D., senior author of a new study on plasma ...

MYND Diagnostics will be initiating a clinical validation study on the use of its proprietary biomarker testing in Multiple Sclerosis diagnostics "According to the National Multiple Sclerosis Society, ...

An estimated 2.8 million people worldwide have multiple sclerosis (MS). This autoimmune condition is the result of the immune system damaging parts of the nerves in the brain and spinal cord, which ...

Roche has received CE mark approval of its Elecsys neurofilament light chain (NfL) test, which is designed to detect neuroinflammation in patients with relapsing remitting multiple sclerosis (RRMS).

Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...